Citations (59)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Raj Kumar, Keshaw Ram Aadil, Kunal Mondal, Yogendra Kumar Mishra, David Oupicky, Seeram Ramakrishna & Ajeet Kaushik. (2022) Neurodegenerative disorders management: state-of-art and prospects of nano-biotechnology. Critical Reviews in Biotechnology 42:8, pages 1180-1212.
Read now
Read now
M.D. Cayero-Otero, Maria João Gomes, Cláudia Martins, J. Álvarez-Fuentes, M. Fernández-Arévalo, B. Sarmento & L. Martín-Banderas. (2019) In vivo biodistribution of venlafaxine-PLGA nanoparticles for brain delivery: plain vs. functionalized nanoparticles. Expert Opinion on Drug Delivery 16:12, pages 1413-1427.
Read now
Read now
Mahendra Rai, Avinash P. Ingle, Swapnil Gaikwad, Felipe Hering Padovani & Monica Alves. (2016) The role of nanotechnology in control of human diseases: perspectives in ocular surface diseases. Critical Reviews in Biotechnology 36:5, pages 777-787.
Read now
Read now
Anjali Hirani, Aditya Grover, Yong W. Lee, Yashwant Pathak & Vijaykumar Sutariya. (2016) Triamcinolone acetonide nanoparticles incorporated in thermoreversible gels for age-related macular degeneration. Pharmaceutical Development and Technology 21:1, pages 61-67.
Read now
Read now
Werner Geldenhuys, Daniel Wehrung, Anastasia Groshev, Anjali Hirani & Vijaykumar Sutariya. (2015) Brain-targeted delivery of doxorubicin using glutathione-coated nanoparticles for brain cancers. Pharmaceutical Development and Technology 20:4, pages 497-506.
Read now
Read now
Jagat R Kanwar, Bhasker Sriramoju & Rupinder K Kanwar. (2012) Neurological disorders and therapeutics targeted to surmount the blood–brain barrier. International Journal of Nanomedicine 7, pages 3259-3278.
Read now
Read now
Werner J Geldenhuys, David D Allen & Jeffrey R Bloomquist. (2012) Novel models for assessing blood–brain barrier drug permeation. Expert Opinion on Drug Metabolism & Toxicology 8:6, pages 647-653.
Read now
Read now
Werner Geldenhuys, Thomas Mbimba, Thong Bui, Kimberly Harrison & Vijaykumar Sutariya. (2011) Brain-targeted delivery of paclitaxel using glutathione-coated nanoparticles for brain cancers. Journal of Drug Targeting 19:9, pages 837-845.
Read now
Read now
Articles from other publishers (51)
Zahra Kaboli, Mir-Jamal Hosseini, Somayeh Sadighian, Kobra Rostamizadeh, Mehrdad Hamidi & Hamidreza Kheiri Manjili. (2023) Valine conjugated polymeric nanocarriers for targeted co-delivery of rivastigmine and quercetin in rat model of Alzheimer disease. International Journal of Pharmaceutics 645, pages 123418.
Crossref
Crossref
Jianru Li, Zixia Zhang, Baoli Zhang, Xiyun Yan & Kelong Fan. (2023) Transferrin receptor 1 targeted nanomedicine for brain tumor therapy. Biomaterials Science 11:10, pages 3394-3413.
Crossref
Crossref
Babita Shashni, Junya Tamaoki, Makoto Kobayashi & Yukio Nagasaki. (2023) Design of a new self-assembling antioxidant nanomedicine to ameliorate oxidative stress in zebrafish embryos. Acta Biomaterialia 159, pages 367-381.
Crossref
Crossref
Divyesh H. Shastri, Ana Catarina Silva & Hugo Almeida. (2023) Ocular Delivery of Therapeutic Proteins: A Review. Pharmaceutics 15:1, pages 205.
Crossref
Crossref
Yue Na, Ning Zhang, Xinyu Zhong, Jinlian Gu, Chang Yan, Shun Yin, Xia Lei, Jihui Zhao & Fang Geng. (2023) Polylactic-co-glycolic acid-based nanoparticles modified with peptides and other linkers cross the blood–brain barrier for targeted drug delivery. Nanomedicine 18:2, pages 125-143.
Crossref
Crossref
Andre Yohan, Christopher Jacques, Tafaswa Fletcher, Thanaphorn Suk-in & Robert B. Campbell. (2022) An Overview of Conventional Drugs and Nanotherapeutic Options for the Treatment
and Management of Pediatric Acute Lymphoblastic Leukemia. Anti-Cancer Agents in Medicinal Chemistry 22:18, pages 3050-3061.
Crossref
Crossref
Miguel Pinto, Vera Silva, Sandra Barreiro, Renata Silva, Fernando Remião, Fernanda Borges & Carlos Fernandes. (2022) Brain drug delivery and neurodegenerative diseases: Polymeric PLGA-based nanoparticles as a forefront platform. Ageing Research Reviews 79, pages 101658.
Crossref
Crossref
Alexander Leathem, Tamara Ortiz-Cerda, Joanne M. Dennis & Paul K. Witting. (2022) Evidence for Oxidative Pathways in the Pathogenesis of PD: Are Antioxidants Candidate Drugs to Ameliorate Disease Progression?. International Journal of Molecular Sciences 23:13, pages 6923.
Crossref
Crossref
Alexander Leathem, Martin Simone, Joanne M. Dennis & Paul K. Witting. (2022) The Cyclic Nitroxide TEMPOL Ameliorates Oxidative Stress but Not Inflammation in a Cell Model of Parkinson’s Disease. Antioxidants 11:2, pages 257.
Crossref
Crossref
Rahul Shankar Tade, Pravin Onkar Patil, Sopan Namdev Nangare, Ashwini Ghanshyam Patil, Mahesh Prabhakar More, Prashant Krishnarao Deshmuk, Zamir Gaffar Khan, Abhieet Pandey, Sai Boddu, Dilip R. Patil, Srinivas Mutalik, Arun M. Patil, Sharad Wakode & Sanjaykumar Baburao Bari. 2022. Polymeric nanoparticles for the treatment of solid tumors. Polymeric nanoparticles for the treatment of solid tumors
373
400
.
Chiad Onyeje & Erin Lavik. (2021) Highlighting the usage of polymeric nanoparticles for the treatment of traumatic brain injury: A review study. Neurochemistry International 147, pages 105048.
Crossref
Crossref
Jiwon Yeo, Junseok Lee, Sanggi Lee & Won Jong Kim. (2021) Polymeric Antioxidant Materials for Treatment of Inflammatory Disorders. Advanced Therapeutics 4:4, pages 2000270.
Crossref
Crossref
William M. Pardridge. (2020) Brain Delivery of Nanomedicines: Trojan Horse Liposomes for Plasmid DNA Gene Therapy of the Brain. Frontiers in Medical Technology 2.
Crossref
Crossref
Federica Rey, Bianca Barzaghini, Alessandra Nardini, Matteo Bordoni, Gian Vincenzo Zuccotti, Cristina Cereda, Manuela Teresa Raimondi & Stephana Carelli. (2020) Advances in Tissue Engineering and Innovative Fabrication Techniques for 3-D-Structures: Translational Applications in Neurodegenerative Diseases. Cells 9:7, pages 1636.
Crossref
Crossref
Rajesh R. Nair, Debbie Piktel, Quincy A. Hathaway, Stephanie L. Rellick, Patrick Thomas, Pushkar Saralkar, Karen H. Martin, Werner J. Geldenhuys, John M. Hollander & Laura F. Gibson. (2020) Pyrvinium Pamoate Use in a B cell Acute Lymphoblastic Leukemia Model of the Bone Tumor Microenvironment. Pharmaceutical Research 37:3.
Crossref
Crossref
Po-Sheng Hu, Natalia Tomasovicova, Hsiu-Jen Chou, Meng-Chang Li, Marek Vojtko, Katarina Zakutanska, Jozefina Majorosova, Shean-Jen Chen & Peter Kopcansky. (2020) Hyperthermia Induced by Near-Infrared Laser-Irradiated CsWO3 Nanoparticles Disintegrates Preformed Lysozyme Amyloid Fibrils. Nanomaterials 10:3, pages 442.
Crossref
Crossref
Sunita Chawla, Dnyaneshwar Kalyane, Vishakha Tambe, Pran Kishore Deb, Kiran Kalia & Rakesh K. Tekade. (2020) Evolving nanoformulation strategies for diagnosis and clinical interventions for Parkinson’s disease. Drug Discovery Today 25:2, pages 392-405.
Crossref
Crossref
Serda Kecel-Gunduz, Bilge Bicak & Aysen E. Ozel. 2020. Neural Regenerative Nanomedicine. Neural Regenerative Nanomedicine
89
122
.
Sanjeev Kumar Paikra, Janmejaya Bag & Monalisa Mishra. 2020. Nanoformulations in Human Health. Nanoformulations in Human Health
259
283
.
Lubna Siddiqui, Harshita Mishra, Sushama Talegaonkar & Mahendra Rai. 2020. Nanoformulations in Human Health. Nanoformulations in Human Health
3
12
.
Kasper Bendix Johnsen, Annette Burkhart, Louiza Bohn Thomsen, Thomas Lars Andresen & Torben Moos. (2019) Targeting the transferrin receptor for brain drug delivery. Progress in Neurobiology 181, pages 101665.
Crossref
Crossref
Kathleen HalaszShannon J. KellyMuhammad Tajwar IqbalYashwant PathakVijaykumar Sutariya. (2019) Micro/Nanoparticle Delivery Systems for Ocular Diseases. ASSAY and Drug Development Technologies 17:4, pages 152-166.
Crossref
Crossref
Garima Sharma, Ashish R. Sharma, Sang-Soo Lee, Manojit Bhattacharya, Ju-Suk Nam & Chiranjib Chakraborty. (2019) Advances in nanocarriers enabled brain targeted drug delivery across blood brain barrier. International Journal of Pharmaceutics 559, pages 360-372.
Crossref
Crossref
Jhonatas Rodrigues Barbosa, Maurício Madson dos Santos Freitas, Luiza Helena da Silva Martins, Andrea Komesu, Alessandra Santos Lopes, Raul Nunes de Carvalho Junior & Mahendra Rai. 2019. Nanobiotechnology in Neurodegenerative Diseases. Nanobiotechnology in Neurodegenerative Diseases
139
162
.
Sunita Lahkar & Malay K. Das. 2019. Surface Modification of Nanoparticles for Targeted Drug Delivery. Surface Modification of Nanoparticles for Targeted Drug Delivery
277
310
.
Natália Tomašovičová, Po-Sheng Hu, Cyun-Lun Zeng, Jozefína Majorošová, Katarína Zakutanská & Peter Kopčanský. (2018) Dual Size-Dependent Effect of Fe3O4 Magnetic Nanoparticles Upon Interaction with Lysozyme Amyloid Fibrils: Disintegration and Adsorption. Nanomaterials 9:1, pages 37.
Crossref
Crossref
Kathleen Halasz, Shannon J. Kelly, Muhammad Tajwar Iqbal, Yashwant Pathak & Vijaykumar Sutariya. (2018) Utilization of Apatinib-Loaded Nanoparticles for the Treatment of Ocular Neovascularization. Current Drug Delivery 16:2, pages 153-163.
Crossref
Crossref
Justin G. Rosch, Anna L. Brown, Allison N. DuRoss, Erin L. DuRoss, Gaurav Sahay & Conroy Sun. (2018) Nanoalginates via Inverse-Micelle Synthesis: Doxorubicin-Encapsulation and Breast Cancer Cytotoxicity. Nanoscale Research Letters 13:1.
Crossref
Crossref
Shannon Kelly, Anjali Hirani, Vishal Shahidadpury, Aum Solanki, Kathleen Halasz, Sheeba Varghese Gupta, Brian Madow & Vijaykumar Sutariya. (2018) Aflibercept Nanoformulation Inhibits VEGF Expression in Ocular In Vitro Model: A Preliminary Report. Biomedicines 6:3, pages 92.
Crossref
Crossref
Rajesh R. Nair, Debbie Piktel, Werner J. Geldenhuys & Laura F. Gibson. (2018) Combination of cabazitaxel and plicamycin induces cell death in drug resistant B-cell acute lymphoblastic leukemia. Leukemia Research 72, pages 59-66.
Crossref
Crossref
Vijaykumar SutariyaJared TurShannon KellyKathleen HalaszKalyan C. ChapalamaduguRohini NimbalkarYashwant V. PathakRobert WeigelTodd DaviauTravis WebbJanice CacaceMarco BrottoSrinivas M. Tipparaju. (2018) Nanodrug delivery platform for glucocorticoid use in skeletal muscle injury. Canadian Journal of Physiology and Pharmacology 96:7, pages 681-689.
Crossref
Crossref
Wang Ran & Xue Xue. (2018) Theranostical application of nanomedicine for treating central nervous system disorders. Science China Life Sciences 61:4, pages 392-399.
Crossref
Crossref
Serge Mignani, Maria Bryszewska, Maria Zablocka, Barbara Klajnert-Maculewicz, Josep Cladera, Dzmitry Shcharbin & Jean-Pierre Majoral. (2017) Can dendrimer based nanoparticles fight neurodegenerative diseases? Current situation versus other established approaches. Progress in Polymer Science 64, pages 23-51.
Crossref
Crossref
Arunachalam Muthuraman & Jaspreet Kaur. 2017. Nanostructures for Antimicrobial Therapy. Nanostructures for Antimicrobial Therapy
139
167
.
Anil Kumar Kalvala, Priyanka Giri, Jyothirmai Kaligatla, Wahid Khan & Ashutosh Kumar. 2017. Advances in Personalized Nanotherapeutics. Advances in Personalized Nanotherapeutics
157
185
.
Lindsey Crawford, Justin Rosch & David Putnam. (2016) Concepts, technologies, and practices for drug delivery past the blood–brain barrier to the central nervous system. Journal of Controlled Release 240, pages 251-266.
Crossref
Crossref
Shringika Soni, Rakesh Kumar Ruhela & Bikash Medhi. (2016) Nanomedicine in Central Nervous System (CNS) Disorders: A Present and Future Prospective. Advanced Pharmaceutical Bulletin 6:3, pages 319-335.
Crossref
Crossref
Rajat Sandhir, Aarti Yadav, Aditya Sunkaria & Nitin Singhal. (2015) Nano-antioxidants: An emerging strategy for intervention against neurodegenerative conditions. Neurochemistry International 89, pages 209-226.
Crossref
Crossref
Ben Newland, Heike Newland, Carsten Werner, Anne Rosser & Wenxin Wang. (2015) Prospects for polymer therapeutics in Parkinson's disease and other neurodegenerative disorders. Progress in Polymer Science 44, pages 79-112.
Crossref
Crossref
Howard E. Gendelman, Vellareddy Anantharam, Tatiana Bronich, Shivani Ghaisas, Huajun Jin, Anumantha G. Kanthasamy, Xinming Liu, JoEllyn McMillan, R. Lee Mosley, Balaji Narasimhan & Surya K. Mallapragada. (2015) Nanoneuromedicines for degenerative, inflammatory, and infectious nervous system diseases. Nanomedicine: Nanotechnology, Biology and Medicine 11:3, pages 751-767.
Crossref
Crossref
Sumati Bhatia & Rainer Haag. 2015. Targeted Drug Delivery : Concepts and Design. Targeted Drug Delivery : Concepts and Design
543
569
.
Aditya Grover, Anjali Hirani, Yashwant Pathak & Vijaykumar Sutariya. (2014) Brain-Targeted Delivery of Docetaxel by Glutathione-Coated Nanoparticles for Brain Cancer. AAPS PharmSciTech 15:6, pages 1562-1568.
Crossref
Crossref
Werner J. Geldenhuys, Akiko Kochi, Li Lin, Vijaykumar Sutariya, Dean E. Dluzen, Cornelis J. Van der Schyf & Mi Hee Lim. (2014) Methyl Yellow: A Potential Drug Scaffold for Parkinson's Disease. ChemBioChem 15:11, pages 1591-1598.
Crossref
Crossref
Joana A Loureiro, Bárbara Gomes, Manuel AN Coelho, Maria do Carmo Pereira & Sandra Rocha. (2014) Targeting nanoparticles across the blood–brain barrier with monoclonal antibodies. Nanomedicine 9:5, pages 709-722.
Crossref
Crossref
Manindra Nath Tiwari, Swati Agarwal, Priyanka Bhatnagar, Naveen Kumar Singhal, Shashi Kant Tiwari, Pradeep Kumar, Lalit Kumar Singh Chauhan, Devendra Kumar Patel, Rajnish Kumar Chaturvedi, Mahendra Pratap Singh & Kailash Chand Gupta. (2013) Nicotine-encapsulated poly(lactic-co-glycolic) acid nanoparticles improve neuroprotective efficacy against MPTP-induced parkinsonism. Free Radical Biology and Medicine 65, pages 704-718.
Crossref
Crossref
E. Garbayo, E. Ansorena & M.J. Blanco-Prieto. (2013) Drug development in Parkinson's disease: From emerging molecules to innovative drug delivery systems. Maturitas 76:3, pages 272-278.
Crossref
Crossref
Dahai Yu, Yuying Zhang, Zhengwei Mao & Changyou Gao. (2013) Study of the Selective Uptake Progress of Aptamer-Modified PLGA Particles by Liver Cells. Macromolecular Bioscience 13:10, pages 1413-1421.
Crossref
Crossref
Xiaowei Lu, Huae Xu, Bo Sun, Zhenshu Zhu, Donghui Zheng & Xiaolin Li. (2013) Enhanced Neuroprotective Effects of Resveratrol Delivered by Nanoparticles on Hydrogen Peroxide-Induced Oxidative Stress in Rat Cortical Cell Culture. Molecular Pharmaceutics 10:5, pages 2045-2053.
Crossref
Crossref
Morteza Mahmoudi, Hamid R. Kalhor, Sophie Laurent & Iseult Lynch. (2013) Protein fibrillation and nanoparticle interactions: opportunities and challenges. Nanoscale 5:7, pages 2570.
Crossref
Crossref
Carmen Giordano, Diego Albani, Antonio Gloria, Marta Tunesi, Serena Rodilossi, Teresa Russo, Gianluigi Forloni, Luigi Ambrosio & Alberto Cigada. (2011) Nanocomposites for Neurodegenerative Diseases: Hydrogel-Nanoparticle Combinations for a Challenging Drug Delivery. The International Journal of Artificial Organs 34:12, pages 1115-1127.
Crossref
Crossref
Virendra Gajbhiye & Narendra K. Jain. (2011) The treatment of Glioblastoma Xenografts by surfactant conjugated dendritic nanoconjugates. Biomaterials 32:26, pages 6213-6225.
Crossref
Crossref